A

Abeona Therapeutics
D

ABEO

6.54000
USD
-0.11
(-1.58%)
مغلق
حجم التداول
18,698
الربح لكل سهم
-1
العائد الربحي
-
P/E
-10
حجم السوق
334,565,053
أصول ذات صلة
C
CRBP
0.18000
(2.00%)
9.17000 USD
P
PLX
-0.04000
(-2.57%)
1.51500 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
S
SLDB
0.34000
(5.11%)
7.00000 USD
S
SYBX
0.06000
(3.90%)
1.60000 USD
المزيد
الأخبار المقالات

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.